Business Segments Exact Sciences Corporation
Stocks
EXAS
US30063P1057
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 21/03/2026 am IST
|
5-day change | 1st Jan Change | ||
| 104.91 USD | +0.95% |
|
-.--% | +3.30% |
| 25/03 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index | CI |
| 25/03 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Device Research and Development | ||||||||||
Biotechnology (Startups) | 176.71Cr | 208.43Cr | 249.98Cr | 275.89Cr | 324.7Cr | |||||
Total Assets | 668.49Cr | 622.69Cr | 647.13Cr | 592.81Cr | 586.06Cr | |||||
Interest Expense | -1.86Cr | -1.96Cr | -1.94Cr | -2.7Cr | -3.94Cr | |||||
Income Tax Expense | -25Cr | -90.64L | 24.03L | -73.04L | 40.61L | |||||
CAPEX | -14Cr | -21Cr | -12Cr | -14Cr | -13Cr | |||||
EBT | -84Cr | -63Cr | -20Cr | -103.62Cr | -20Cr | |||||
Gross Profit | - | - | - | 191.87Cr | 226.28Cr | |||||
D&A | 18Cr | 20Cr | 21Cr | 21Cr | 22Cr | |||||
Operating Income | -86Cr | -59Cr | -22Cr | -104.87Cr | -21Cr | |||||
Net Income | -60Cr | -62Cr | -20Cr | -102.89Cr | -21Cr |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 165.72Cr | 196.65Cr | 234.65Cr | 256.98Cr | 302.31Cr | |||||
Total Assets | - | 622.69Cr | 647.13Cr | 592.81Cr | 586.06Cr | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
| - | - | - | - | 22Cr | ||||||
Outside of United States | 11Cr | 12Cr | 15Cr | 19Cr | 22Cr | |||||
| - | - | - | - | 302.31Cr |
- Stock Market
- Stocks
- EXAS Stock
- Financials Exact Sciences Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
